ask="2.350"
ask_size="200"
average_daily_volume="157923"
bid="2.000"
bid_size="2000"
book_value="1.476"
change="+0.075"
change_from_200_day_moving_average="0.399"
change_from_50_day_moving_average="0.442"
change_from_52_week_high="-1.175"
change_From_52_week_low="1.075"
change_in_percent="+3.571%"
close="2.175"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.329"
ebitda="-17.29M"
eps_estimate_current_year="-1.100"
eps_estimate_next_quarter="-0.210"
eps_estimate_next_year="-0.540"
ex_dividend_date="N/A"
float_shares="11990000"
high="2.250"
high_52_weeks="3.350"
last_trade_date="2/3/2017"
last_trade_price="2.175"
last_trade_size="585"
last_trade_time="4:00pm"
low="2.100"
low_52_weeks="1.100"
market_capitalization="41.08M"
moving_average_200_day="1.776"
moving_average_50_day="1.733"
name="Cancer Genetics
Inc."
notes="N/A"
one_year_target_price="6.580"
open="2.150"
pe_ratio="N/A"
peg_ratio="-0.050"
percent_change_from_200_day_moving_average="+22.453%"
percent_change_from_50_day_moving_average="+25.524%"
percent_change_from_52_week_high="-35.075%"
percent_change_from_52_week_low="+97.727%"
previous_close="2.100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.423"
price_per_sales="1.568"
revenue="25.30M"
shares_outstanding="18887000"
short_ratio="1.780"
stock_exchange="NCM"
symbol="CGIX"
volume="175511"
weeks_range_52="1.100 - 3.350"
